MK0954A-264 Filter Study (0954A-264)(COMPLETED)

NCT00307060 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

274

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Severe Hypertension

Interventions

DRUG: MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 6 weeks
DRUG: losartan / Duration of Treatment: 6 weeks

Sponsor

Organon and Co